Radiotherapy for T1-2N0 glottic cancer: A multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients

Clinical Otolaryngology

Volumn 38, Issue 4, 2013, Pages 306-312

  Al Mamgani, A ^a   van Rooij, P H ^a   Woutersen, D P ^b   Mehilal, R ^a   Tans, L ^a   Monserez, D ^a   Baatenburg de Jong, R J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; DETERIORATION; DISEASE FREE SURVIVAL; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; RETROSPECTIVE STUDY; SMOKING; SURVIVAL RATE; VOICE HANDICAP INDEX; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VOICE DISORDERS;

EID: 84882747047     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/coa.12139     Document Type: Article

References (23)

1. http://www.oncoline.nl/richtlijn/item/index.php?pagina=/richtlijn/item/pagina.php&richtlijn_id=666.
2. Hartl D.M., Ferlito A., Brasnu D.F. et al. (2011) Evidence-based review of treatment options for patients with glottic cancer. Head Neck 11, 1638-1648
3. Wiggenraad R.G., Terhaard C.H., Hordijk G.J. et al. (1990) The importance of vocal cord mobility in T2 laryngeal cancer. Radiother. Oncol. 18, 321-327
4. Jacobson G., Johnson A., Grywalski C. et al. (1997) The Voice Handicap Index (VHI): development and validation. Am. J. Speech Lang. Pathol. 6, 66-70
5. Mendenhall W.M., Werning J.W., Hinerman R.W. et al. (2004) Management of T1-T2 glottic carcinomas. Cancer 100, 1786-1792
6. van Loon Y., Sjogren E.V., Langeveld T.P. et al. (2012) Functional outcomes after radiotherapy or laser surgery in early glottic carcinoma: a systematic review. Head Neck 34, 1179-1189
7. 2 laser surgery as treatment option. Head Neck 30, 1167-1172
8. Cohen S.M., Garrett C.G., Dupont W.D. et al. (2006) Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. Ann. Otol. Rhinol. Laryngol. 115, 581-586
9. van Gogh C.D., Verdonck-de Leeuw I.M., Wedler-Peeters J. et al. (2012) Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma. Eur. Arch. Otorhinolaryngol. 269, 1647-1652
10. Sjogren E.V., van Rossum M.A., Langeveld T.P.M. et al. (2008) Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch. Otolaryngol. Head Neck Surg. 134, 965-972
11. Sjogren E.V., van Rossum M.A., Langeveld T.P. et al. (2009) Voice profile after type I or II laser chordectomies for T1a glottic carcinoma. Head Neck 31, 1502-1510
12. Nonoshita T., Shioyama Y., Kunitake N. et al. (2009) Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma. Fukuoka Igaku Zasshi 1, 26-31
13. McCoul E.D. & El-Har G. (2009) Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma. Arch. Otolaryngol. Head Neck Surg. 135, 479-486
14. Overgaard J., Hansen H.S., Specht L. et al. (2003) Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362, 933-940
15. Yamazaki H., Nishiyama K., Tanaka E. et al. (2006) Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int. J. Radiat. Oncol. Biol. Phys. 64, 77-82
16. Bourhis J., Overgaard J., Audry H. et al. (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368, 843-854
17. Terhaard C.H., Snippe K., Ravasz L.A. et al. (1991) Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int. J. Radiat. Oncol. Biol. Phys. 21, 1179-1186
18. Persky M.S., Lagmay V.M., Cooper J. et al. (2000) Curative radiotherapy for anterior commissure laryngeal carcinoma. Ann. Otol. Rhinol. Laryngol. 109, 156-159
19. Mlynarek A., Kost K. & Gesser R. (2006) Radiotherapy versus surgery for early T1-T2 glottic carcinoma. J. Otolaryngol. 35, 413-419
20. Warde P., O'Sullivan B., Bristow R.G. et al. (1998) T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int. J. Radiat. Oncol. Biol. Phys. 41, 347-353
21. Nishiyama K., Tanaka E., Tarui Y. et al. (1996) A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int. J. Radiat. Oncol. Biol. Phys. 34, 439-444
22. Leon X., Gras J.R., Perez A. et al. (2002) Hypothyroidism in patients treated with total laryngectomy. A multivariate study. Eur. Arch. Otorhinolaryngol. 259, 193-196
23. Lo Galbo A.M., de Bree R., Lips P. et al. (2009) Detecting hypothyroidism after treatment for laryngeal or hypopharyngeal carcinomas: a nationwide survey in The Netherlands. Eur. Arch. Otorhinolaryngol. 266, 713-718